Healthcare -
Biotechnology - NASDAQ - US
$ 3.685
0.136 %
$ 260 M
Market Cap
-2.15
P/E
Price Target
Average
279.92%
Revenue Forecast
Estimate
--1.64%
EBIT
Estimate
--2.46%
Net Income
Estimate
--0.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
C4 Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for CCCC of $14 , with forecasts ranging from
a
low of
$9 to a high of $20 .
CCCC Lowest Price Target
Wall Street Target
9 USD
144.23%
CCCC Average Price Target
Wall Street Target
14 USD
279.92%
CCCC Highest Price Target
Wall Street Target
20 USD
442.74%
REVENUE FORECAST
Revenue Forecast Chart CCCC
EBIT FORECAST
EBIT Forecast Chart CCCC
NET INCOME FORECAST
Net Income Chart CCCC